基因组学服务市场机会、成长动力、产业趋势分析及 2025 - 2034 年预测

Genomics Services Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

出版日期: 2025年03月25日 | 出版商:

Global Market Insights Inc. | 英文 138 Pages | 商品交期: 2-3个工作天内

价格

简介目录

全球基因组学服务市场价值 85 亿美元，预计 2025 年至 2034 年的复合年增长率为 11.5%。由于遗传疾病盛行率不断上升以及对个人化医疗的日益重视，市场正在不断扩大。随着对遗传学理解的不断深入，对基因组服务的需求正在激增，尤其是精准医疗在治疗方案中的日益融合。在基因检测和基因定序技术的进步推动下，全球医疗保健领域正在转向更个人化的方法。这些发展为早期诊断、针对性治疗和改善患者预后铺平了道路。世界各国政府和私人组织正在大力投资基因组研究，越来越注重提高诊断准确性和开发新疗法。随着精准医疗的兴起，基因组服务在研究、临床诊断和治疗开发中变得越来越不可或缺，为未来十年市场实现显着成长奠定了基础。

包括下一代定序（NGS）在内的尖端技术的发展是推动基因组学服务市场向前发展的关键驱动力。生物技术新创公司和成熟的行业领导者正在积极投资研发，以改进这些技术并增强其能力。定序成本的下降进一步加速了NGS的采用，使得研究人员和临床医生能够快速且准确地对DNA和RNA进行定序。与传统方法相比，该技术可以在很短的时间内识别基因突变或变异，使其成为研究和临床诊断的首选。 2023 年，光是次世代定序领域就创造了 27 亿美元的收入，凸显了其在推动基因组研究和个人化医疗方面的关键作用。此外，其他突出的服务类型包括基因分型、微阵列和桑格测序，每种服务类型都透过提供针对不同研究和临床需求的专门解决方案来促进市场的成长。

市场范围
起始年份	2024
预测年份	2025-2034
起始值	85亿美元
预测值	250亿美元
复合年增长率	11.5%

基因组学服务市场分为研究和诊断，其中研究部分在 2024 年占据 63.6% 的市场。政府和私营部门对基因组研究的投资不断增加，推动了这一领域的成长。学术机构和生物技术公司正在利用基因组服务来研究基因结构、功能和变异，促进新疗法的发现并提高对遗传疾病的理解。基因组学在药物发现和临床研究中的快速应用凸显了基因组服务在转变现代医疗保健方面日益增长的重要性。

美国基因组学服务市场预计也将经历强劲成长，到 2034 年将维持 11.5% 的复合年增长率。这一增长得益于政府对基因组学研究的大量资助、先进研究设施的可用性以及公众对精准医疗的认识不断提高。美国继续引领全球基因组学领域，其完善的基础设施以及公共和私人实体之间的密切合作促进了基因组服务的快速发展。对基因组研究的日益重视以及精准医疗与临床工作流程的整合强化了基因组学在医疗保健和药物开发中的重要性，为未来几年市场持续增长奠定了基础。

产业生态系统分析
产业衝击力
- 成长动力
  - 基因组学技术进步
  - 遗传性疾病盛行率上升
  - 基因组学在专科或个人化医疗的应用日益增多
- 产业陷阱与挑战
  - 缺乏训练有素的基因组学专业人员
  - 建立基因组实验室的成本高昂
成长潜力分析
监管格局
未来市场趋势
波特的分析
PESTEL分析

第四章：竞争格局

介绍
公司矩阵分析
主要市场参与者的竞争分析
竞争定位矩阵
策略仪表板

第五章：市场估计与预测：按服务类型，2021-2034 年

主要趋势
下一代定序
基因分型
微阵列
桑格定序
其他服务

第六章：市场估计与预测：按应用，2021-2034

主要趋势
研究
诊断

第七章：市场估计与预测：依最终用途，2021-2034

主要趋势
研究机构
诊断中心
製药和生物技术公司
合约研究组织（CRO）
其他最终用途

第八章：市场估计与预测：按地区，2021-2034

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 荷兰
亚太地区
- 中国
- 日本
- 印度
- 澳洲
- 韩国
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
中东和非洲
- 南非
- 沙乌地阿拉伯
- 阿联酋

第九章：公司简介

23andMe
Agilent Technologies
BGI Genomics
Bio Rad Laboratories
Color Genomics
Danaher
Eurofins Scientific
F. Hoffmann-La Roche
GE Healthcare
GENEWIZ (Azenta)
Illumina
LGC
Macrogen
IQVIA
QIAGEN

简介目录

Product Code: 5811

The Global Genomics Services Market, valued at USD 8.5 billion in 2024, is projected to grow at a CAGR of 11.5% from 2025 to 2034. The market is expanding due to the increasing prevalence of genetic disorders and the rising emphasis on personalized medicine. As the understanding of genetics deepens, the demand for genomic services is surging, particularly with the growing integration of precision medicine in treatment protocols. The global healthcare landscape is witnessing a shift toward more personalized approaches driven by advancements in genetic testing and gene sequencing technologies. These developments are paving the way for early diagnosis, targeted treatments, and improved patient outcomes. Governments and private organizations worldwide are investing heavily in genomic research, with an increasing focus on enhancing diagnostic accuracy and developing new therapies. As precision medicine gains traction, genomic services are becoming indispensable in research, clinical diagnostics, and therapeutic development, positioning the market for significant growth over the next decade.

The development of cutting-edge technologies, including next-generation sequencing (NGS), is a critical driver propelling the genomics services market forward. Biotechnology startups and established industry leaders are actively investing in research and development to refine these technologies and enhance their capabilities. The declining cost of sequencing has further accelerated the adoption of NGS, allowing researchers and clinicians to sequence DNA and RNA quickly and accurately. This technology can identify gene mutations or variations in a fraction of the time compared to traditional methods, making it a preferred choice in both research and clinical diagnostics. In 2023, the next-generation sequencing segment alone generated USD 2.7 billion, underscoring its pivotal role in advancing genomic research and personalized medicine. Additionally, other prominent service types include genotyping, microarrays, and Sanger sequencing, each contributing to the market's growth by offering specialized solutions tailored to different research and clinical needs.

Market Scope
Start Year	2024
Forecast Year	2025-2034
Start Value	$8.5 Billion
Forecast Value	$25 Billion
CAGR	11.5%

The genomics services market is divided between research and diagnostics, with the research segment accounting for 63.6% of the market share in 2024. The increasing investments from both government and private sectors in genomic research are driving the growth of this segment. Academic institutions and biotechnology companies are leveraging genomic services to study gene structure, function, and variation, facilitating the discovery of novel therapies and improving the understanding of genetic disorders. The rapid adoption of genomics in drug discovery and clinical research highlights the growing importance of genomic services in transforming modern healthcare.

The U.S. Genomics Services Market is also expected to witness robust growth, maintaining a CAGR of 11.5% through 2034. This growth is fueled by substantial government funding for genomic research, the availability of advanced research facilities, and increasing public awareness of precision medicine. The United States continues to lead the global genomics landscape, with its well-established infrastructure and strong collaborations between public and private entities contributing to the rapid advancement of genomic services. The growing emphasis on genomic research and the integration of precision medicine into clinical workflows reinforce the significance of genomics in healthcare and drug development, positioning the market for sustained growth in the coming years.

Chapter 1 Methodology and Scope

1.1 Market scope and definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Technological advancements in genomics
  - 3.2.1.2 Rising prevalence of genetic disorders
  - 3.2.1.3 Increasing usage of genomics in specialized or personalized medicines
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 Shortage of trained genomics professionals
  - 3.2.2.2 High costs of establishing genomic laboratories
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Future market trends
3.6 Porter's analysis
3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Service Type, 2021-2034 ($ Mn)

5.1 Key trends
5.2 Next generation sequencing
5.3 Genotyping
5.4 Microarray
5.5 Sanger sequencing
5.6 Other services

Chapter 6 Market Estimates and Forecast, By Application, 2021-2034 ($ Mn)

6.1 Key trends
6.2 Research
6.3 Diagnostics

Chapter 7 Market Estimates and Forecast, By End Use, 2021-2034 ($ Mn)

7.1 Key trends
7.2 Research institutes
7.3 Diagnostic centers
7.4 Pharmaceutical and biotechnological companies
7.5 Contract research organization (CROs)
7.6 Other end use

Chapter 8 Market Estimates and Forecast, By Region, 2021-2034 ($ Mn)

8.1 Key trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Netherlands
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
8.6 Middle East and Africa
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 UAE